ITCI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Intra-cellular Therapies, Inc. Is Fair to Shareholders
Portfolio Pulse from
Halper Sadeh LLC is investigating the fairness of the sale of Intra-Cellular Therapies, Inc. to Johnson & Johnson for $132 per share. The law firm is assessing whether the deal is in the best interest of ITCI shareholders.
February 25, 2025 | 4:30 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Halper Sadeh LLC is investigating the fairness of the sale of Intra-Cellular Therapies to Johnson & Johnson for $132 per share, raising questions about the deal's benefit to shareholders.
The investigation by Halper Sadeh LLC into the fairness of the sale could impact shareholder sentiment and potentially influence the deal's outcome. However, the investigation itself does not immediately affect the stock price until further developments occur.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100